pHDM-Tat1b Citations (9)

Originally described in: COVID-19-neutralizing antibodies predict disease severity and survival.
Garcia-Beltran WF, Lam EC, Astudillo MG, Yang D, Miller TE, Feldman J, Hauser BM, Caradonna TM, Clayton KL, Nitido AD, Murali MR, Alter G, Charles RC, Dighe A, Branda JA, Lennerz JK, Lingwood D, Schmidt AG, Iafrate AJ, Balazs AB Cell. 2021 Jan 21;184(2):476-488.e11. doi: 10.1016/j.cell.2020.12.015. Epub 2020 Dec 15. PubMed Journal

---

Articles Citing pHDM-Tat1b

Articles
CRISPR/Cas9 Ablation of Integrated HIV-1 Accumulates Proviral DNA Circles with Reformed Long Terminal Repeats. Lai M, Maori E, Quaranta P, Matteoli G, Maggi F, Sgarbanti M, Crucitta S, Pacini S, Turriziani O, Antonelli G, Heeney JL, Freer G, Pistello M. J Virol. 2021 Nov 9;95(23):e0135821. doi: 10.1128/JVI.01358-21. Epub 2021 Sep 22. PubMed
Fast in vitro protocol for the visualization and quantitative high-throughput analysis of sprouting angiogenesis by confocal microscopy. Kempers L, van der Bijl I, van Stalborch AD, Ponsioen B, Margadant C. STAR Protoc. 2021 Sep 13;2(3):100690. doi: 10.1016/j.xpro.2021.100690. eCollection 2021 Sep 17. PubMed
Inhibition of mTOR signaling protects human glioma cells from hypoxia-induced cell death in an autophagy-independent manner. Dive I, Klann K, Michaelis JB, Heinzen D, Steinbach JP, Munch C, Ronellenfitsch MW. Cell Death Discov. 2022 Oct 6;8(1):409. doi: 10.1038/s41420-022-01195-y. PubMed
Changes within the P681 residue of spike dictate cell fusion and syncytia formation of Delta and Omicron variants of SARS-CoV-2 with no effects on neutralization or infectivity. Kuzmina A, Korovin D, Cohen Lass I, Atari N, Ottolenghi A, Hu P, Mandelboim M, Rosental B, Rosenberg E, Diaz-Griffero F, Taube R. Heliyon. 2023 Jun;9(6):e16750. doi: 10.1016/j.heliyon.2023.e16750. Epub 2023 Jun 3. PubMed
Early activation of inflammatory pathways in UBA1-mutated hematopoietic stem and progenitor cells in VEXAS. Wu Z, Gao S, Gao Q, Patel BA, Groarke EM, Feng X, Manley AL, Li H, Ospina Cardona D, Kajigaya S, Alemu L, Quinones Raffo D, Ombrello AK, Ferrada MA, Grayson PC, Calvo KR, Kastner DL, Beck DB, Young NS. Cell Rep Med. 2023 Aug 15;4(8):101160. doi: 10.1016/j.xcrm.2023.101160. PubMed
Imaging and quantitative analysis of integrin-dependent cell-matrix adhesions. van Stalborch AD, Clark AG, Sonnenberg A, Margadant C. STAR Protoc. 2023 Sep 15;4(3):102473. doi: 10.1016/j.xpro.2023.102473. Epub 2023 Aug 23. PubMed
Viral and immunologic evaluation of smokers with severe COVID-19. Vecchio J, Regan J, Jiang Y, Li R, Romain H, Yousuf F, Adel T, Hall K, DaCosta JM, Yu X, Li JZ, Fofana IB. Sci Rep. 2023 Oct 19;13(1):17898. doi: 10.1038/s41598-023-45195-z. PubMed
Safety and immunogenicity of CoronaVac and ChAdOx1 heterologous prime-boost vaccines in an overweight population in Chiang Mai, Thailand. Chawansuntati K, Sakkhachornphop S, Hongjaisee S, Freeouf S, Sripan P, Nusartsang N, Chaiwarith R, Sudjaritruk T, Supparatpinyo K, Wipasa J. Vaccine X. 2024 Mar 16;18:100475. doi: 10.1016/j.jvacx.2024.100475. eCollection 2024 Jun. PubMed
Tumor Cell-Associated IL-1alpha Affects Breast Cancer Progression and Metastasis in Mice through Manipulation of the Tumor Immune Microenvironment. Krishnamohan M, Kaplanov I, Maudi-Boker S, Yousef M, Machluf-Katz N, Cohen I, Elkabets M, Titus J, Bersudsky M, Apte RN, Voronov E, Braiman A. Int J Mol Sci. 2024 Apr 2;25(7):3950. doi: 10.3390/ijms25073950. PubMed

If you have published an article using this material, please email us at to have your article added to this page.